Diabetes mellitus Nutritional, Metabolic, Endocrine Diabetes mellitus
Conditions
Interventions
Participants will wear up to four FreeStyle Libre Sensors for up to 14 days. There is no follow-up period unless the participant experiences an unanticipated adverse device effect (UADE).
Sponsors
Abbott (United Kingdom)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or over 2. Has type 1 or type 2 diabetes or has not been diagnosed as having diabetes 3. Be willing and able to test their blood glucose levels at least four times a day
Exclusion criteria
Exclusion criteria: 1. Has another form of diabetes e.g. maturity-onset diabetes of the young (MODY) 2. Have a known (or suspected) allergy to medical grade adhesive 3. Have a skin abnormality at the application sites 4. Have a pacemaker or any other neurostimulators 5. Have concomitant medical condition which in the participant’s opinion could interfere with the study or present a risk to their safety or welfare, or that of the study team
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy of the FreeStyle Libre Glucose Monitoring Systems compared to capillary fingerstick blood glucose values (FreeStyle Optium blood glucose test strips) using the consensus error grid at the end of the sensor wear period | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
United Kingdom
Contacts
Public ContactPamela Reid
Outcome results
None listed